KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Elevance Health (ELV) Income from Non-Controlling Interests (2021 - 2025)

Elevance Health (ELV) has disclosed Income from Non-Controlling Interests for 4 consecutive years, with -$8.0 million as the latest value for Q3 2024.

  • On a quarterly basis, Income from Non-Controlling Interests changed N/A to -$8.0 million in Q3 2024 year-over-year; TTM through Sep 2024 was $13.0 million, a N/A change, with the full-year FY2024 number at -$9.0 million, down 325.0% from a year prior.
  • Income from Non-Controlling Interests was -$8.0 million for Q3 2024 at Elevance Health, down from $3.0 million in the prior quarter.
  • In the past five years, Income from Non-Controlling Interests ranged from a high of $15.0 million in Q1 2023 to a low of -$10.0 million in Q1 2022.
  • A 4-year average of $1.7 million and a median of $2.5 million in 2021 define the central range for Income from Non-Controlling Interests.
  • Peak YoY movement for Income from Non-Controlling Interests: plummeted 600.0% in 2022, then soared 250.0% in 2023.
  • Elevance Health's Income from Non-Controlling Interests stood at $8.0 million in 2021, then skyrocketed by 50.0% to $12.0 million in 2022, then plummeted by 75.0% to $3.0 million in 2023, then plummeted by 366.67% to -$8.0 million in 2024.
  • Per Business Quant, the three most recent readings for ELV's Income from Non-Controlling Interests are -$8.0 million (Q3 2024), $3.0 million (Q1 2024), and $3.0 million (Q2 2023).